2025 annual financial data

MoonLake Immunotherapeutics 2025 Operating margin

MoonLake Immunotherapeutics 2025 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -244,834,000 USD and net income was -227,318,000 USD.
Operating cash flow was -196,007,000 USD.

Get free MoonLake Immunotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-244,834,000 USD
Net income
-227,318,000 USD
Operating cash flow
-196,007,000 USD